Bioverativ
Global biotechnology company dedicated to transforming the lives of people living with hemophilia and other blood disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
€10.5b (Public information from Jan 2018)
Waltham Massachusetts (HQ)
Authorizing premium user...